Alan Bash insider trades

Open-market stock purchases and sales by Alan Bash, Interim CEO at Legend Biotech Corp, from SEC Form 4 filings since Mar 1, 2022.

Recent trades

DateStockTradeValue
Aug 14, 2026LEGN Legend Biotech CorpBought (not open market)—

Companies traded

  • LEGN Legend Biotech Corp: other filings, last Aug 14, 2026
  • CMPI Checkmate Pharmaceuticals, Inc: other filings, last May 31, 2022

Get free alerts when Alan Bash files a new trade →